Cândida Fonseca

Invited Assistant Professor, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Cândida Fonseca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

17 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

15101 Citations
22 h-Index
57 Article
10 Review article
5 Editorial
4 Other contribution
More

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report
Falcão, F., Viegas, E., Carmo, I., Soares, J., Falcao, M., Solano, M., Cavaco, P., Mendes, D., Rijo, J., Povoa, P., Pais Martins, A., Carmo, E., Mansinho, K., Fonseca, C., Campos, L., Carvalho, A., Mirco, A., Farinha, H., Aldir, I. & Correia, J., 15 Jan 2021, In : European journal of hospital pharmacy : science and practice.
Research output: Contribution to journal › Article

Open Access
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Michael Felker, G., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sorensen, T., Bohm, M., Bonderman, D., Cleland, J. G. F., Corbalan, R., Crespo-Leiro, M. G., Dahlstrom, U., Echeverria, L. E., Fang, J. C., Filippatos, G., Fonseca, C. & 30 others, Goncalvesova, E., Goudev, A. R., Howlett, J. G., Lanfear, D. E., Li, J., Lund, M., Macdonald, P., Mareev, V., Momomura, S., O'Meara, E., Parkhomenko, A., Ponikowski, P., Ramires, F. J. A., Serpytis, P., Sliwa, K., Spinar, J., Suter, T. M., Tomcsanyi, J., Vandekerckhove, H., Vinereanu, D., Voors, A. A., Yilmaz, M. B., Zannad, F., Sharpsten, L., Legg, J. C., Varin, C., Honarpour, N., Abbasi, S. A., Malik, F. I. & Kurtz, C. E., 14 Jan 2021, In : New England Journal Of Medicine. 384, 2, p. 105-116 12 p.
Research output: Contribution to journal › Article
14 Citations (Scopus)
Dapagliflozin in a Real-World Chronic Heart Failure Population: How Many Are Actually Eligible?
Maltês, S., Cunha, G. J. L., Rocha, B. M. L., Presume, J., Guerreiro, R., Henriques, C., Rodrigues, C., Araújo, I. & Fonseca, C., 2021, (Accepted/In press) In : Cardiology (Switzerland).
Research output: Contribution to journal › Article
ARNIs: balancing "the good and the bad" of neuroendocrine response to HF
Ferrari, R., Cardoso, J., Fonseca, M. C., Aguiar, C., Moreira, J. I., Fucili, A. & Rapezzi, C., May 2020, In : Clinical Research in Cardiology. 109, 5, p. 599-610
Research output: Contribution to journal › Article
1 Citation (Scopus)
Current costs of heart failure in Portugal and expected increases due to population aging
Gouveia, M. R. D. A., Ascenção, R. M. S. E. S., Fiorentino, F., Costa, J. N. M. P. G. D., Broeiro-Gonçalves, P. M., Fonseca, C. & Borges, M. D. F. P. F., Jan 2020, In : Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology. 39, 1, p. 3-11 9 p.
Research output: Contribution to journal › Article
3 Citations (Scopus)

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report

Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

Dapagliflozin in a Real-World Chronic Heart Failure Population: How Many Are Actually Eligible?

ARNIs: balancing "the good and the bad" of neuroendocrine response to HF

Current costs of heart failure in Portugal and expected increases due to population aging